GSK launches $50M bioelectronics venture fund

08/8/2013 | Reuters

GlaxoSmithKline launched a $50 million strategic venture capital fund to further the development of so-called bioelectronics or electroceuticals, which use electrical impulses rather than chemicals or biological molecules to treat disease. Ultimately, nanoscale implants could be developed to encourage insulin production, correct muscle imbalances or regulate food consumption, for example.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID